Here's a summary of the provided transcript in a self-contained bullet list format, including timestamps, important details, and key takeaways:

TWiV 1198: Measles and Clinical Update with Dr. Daniel Griffin

• 0:33 Introduction: Dr. Daniel Griffin provides a clinical update from Thailand (recording on March 8th, Thailand time, while it's still March 7th in New York).

• 2:08 Ebola Outbreak: Reports of Ebola cases, including deaths of children, in Uganda. Concerns are raised about the Trump administration's cancellation of US aid contracts that supported Ebola screening and protective measures in Uganda.

• 5:52 Polio Concerns: Continued use of the novel oral polio vaccine type 2 (nOPV2) in Gaza, despite the known risk of vaccine-associated paralytic poliomyelitis (VAPP) and circulating vaccine-derived polioviruses. The ethical implications of continuing nOPV2 use are discussed.

• 8:20 Measles Outbreak: Extensive discussion on the growing measles outbreak in the US, particularly in Texas and New Mexico, including reports of deaths.

• 9:44 RFK Jr.'s Response: Robert F. Kennedy Jr. initially downplayed the outbreak but later acknowledged its severity, announcing vaccine distribution. This caused backlash from his anti-vaccine supporters.

• 10:50 History, Efficacy and Safety of Measles Vaccine The doctors on the podcast discuss the extensive clinical trial data on measles.

• 11:53 Measles Deep Dive: A detailed overview of measles is provided, including:

  • Discovery of the pathogen in 1757.
  • Typical symptoms and progression (4-day fever, cough, coryza, conjunctivitis, rash).
  • Historical impact and mortality, even before vaccines.
  • Reduction in mortality due to antibiotics (for secondary bacterial infections).
  • Long-term effects, including immune amnesia.
  • The doctors reviewed multiple efficacy trials, including a trial where 4 children died in the unvacinated control group.

• 23:41 Measles Vaccination Recommendations:

  • Individuals born before 1957 are considered immune due to widespread measles exposure.
  • Those vaccinated in the 1960s (before 1968) may have received an ineffective inactivated vaccine and should be revaccinated.
  • Modern MMR vaccine (introduced in 1971) requires two doses.

• 26:09 Measles Treatment: Discussion of treatment options, emphasizing that vitamin A may have some benefit in resource-limited settings with malnutrition, but its effectiveness in the US is uncertain.

  • 27:17 Ineffective/Harmful Treatments: Steroids, antibiotics (unless there's a secondary bacterial infection), cod liver oil, and Ivermectin are not recommended and can be harmful.
  • The importance of getting medical advice from pediatricians, not social media or political appointees.

• 28:24 No Measles Parties: Emphatic warning against intentional measles exposure, highlighting the safety and effectiveness of the vaccine.

• 30:54 Respiratory Illness Update:

  • Influenza levels are high but decreasing.
  • RSV levels are high but decreasing.
  • COVID-19 levels are decreasing, but some states still have high mortality.

• 32:03 Wastewater Surveillance: Wastewater data shows decreasing trends for SARS-CoV-2 across the board, but the summer peak was unexplainably higher than the winter peak.

• 32:46 SARS-CoV-2 Variants: Discussion of circulating variants (XCC being replaced by LP.81), though their relevance to vaccine selection is currently unclear.

• 33:06 COVID-19 Vaccine Effectiveness: Interim estimates show the 2024-2025 COVID-19 vaccine is 33% effective against ER/Urgent Care visits and 46% effective against hospitalization in adults over 65. Mostly mRNA vaccines are used, Novavax (protein-based) is an alternative.

• 34:57 Early viral phase treatment of COVID is still largely Paxlovid.

• 35:58 REM Desevir Timing: A study shows early (but not delayed) Remdesivir treatment is associated with reduced mortality in hospitalized COVID-19 patients not requiring or requiring only non-invasive supplemental oxygen.

• 37:30 Public Health Message: "No one is safe until everyone is safe," emphasizing the global nature of disease outbreaks.

• 37:38 Call for donations for Floating Doctors.

• 38:02 Listener Questions:

  • 38:07 Paxlovid Effectiveness: Clarification that despite some studies questioning Paxlovid's efficacy, there is overwhelming evidence of its benefit, especially in high-risk individuals.
  • 39:58 H5N1 in Flu Shots: Discussion of the possibility of adding an H5N1 strain to flu shots, but it's not currently being considered.
  • 40:40 Vitamin A and Measles (Again): Reiteration of the limited evidence for vitamin A's role in measles treatment and its lack of preventive effect.
  • 41:53 Bird Flu and Backyard Birds: No recommendation to stop using bird feeders or bird baths due to bird flu at this time.